Corvus Pharmaceuticals, Inc.
CRVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $13 | $13 | $63 |
| Short-Term Investments | $43 | $15 | $29 | $6 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $1 | $1 |
| Total Curr. Assets | $54 | $28 | $44 | $71 |
| Property Plant & Equip (Net) | $1 | $1 | $3 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $13 | $16 | $22 | $34 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $15 | $18 | $25 | $38 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $69 | $46 | $68 | $109 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $2 | $2 |
| Short-Term Debt | $0 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $33 | $4 | $8 | $7 |
| Total Curr. Liab. | $35 | $7 | $11 | $10 |
| LT Debt | $1 | $0 | $1 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $0 | $1 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $3 | $4 |
| Total Liabilities | $36 | $7 | $12 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$397 | -$335 | -$308 | -$266 |
| AOCI | -$1 | -$1 | -$1 | $2 |
| Other Equity | $431 | $374 | $364 | $362 |
| Total Equity | $33 | $39 | $56 | $97 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $69 | $46 | $68 | $109 |
| Net Debt | -$8 | -$11 | -$11 | -$60 |